Nifty
Sensex
:
:
10813.45
36737.69
107.70 (1.01%)
408.68 (1.12%)

Pharmaceuticals & Drugs - Domestic

Rating :
89/99

BSE: 506820 | NSE: ASTRAZEN

3471.25
09-Jul-2020
  • Open
  • High
  • Low
  • Previous Close
  •  3475.00
  •  3514.35
  •  3447.25
  •  3463.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  20586
  •  717.23
  •  3670.00
  •  1632.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,660.75
  • 119.94
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,487.45
  • 0.03%
  • 23.76

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 2.66%
  • 16.75%
  • FII
  • DII
  • Others
  • 1.22%
  • 3.49%
  • 0.88%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 7.09
  • 10.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 14.06

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 39.52

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 81.03
  • 112.21
  • 105.90

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.01
  • 20.01
  • 20.01

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 41.62
  • 65.98
  • 55.96

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • AstraZeneca Pharma gets import, market permission from DCGI for Dapagliflozin film coated tablet
    6th Jul 2020, 08:52 AM

    Dapagliflozin film coated tablet 10mg is additional indication in adults for the treatment of heart failure with reduced ejection fraction

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.